Discovery of a novel submicromolar inhibitor of the lymphoid specific tyrosine phosphatase.

Discovery of a novel submicromolar inhibitor of the lymphoid specific tyrosine phosphatase.
复制标题

DOI:
10.1016/j.bmcl.2008.03.079
复制
发表时间:
2008-05
影响因子:
2.7
通讯作者:
Yuli Xie;Yidong Liu;G. Gong;A. Rinderspacher;S. Deng;Deborah H. Smith;Udo Toebben;Effie Tzilianos;L. Brandén;D. Vidović;Caty Chung;S. Schürer;L. Tautz;D. Landry
Yuli Xie;Yidong Liu;G. Gong;A. Rinderspacher;S. Deng;Deborah H. Smith;Udo Toebben;Effie Tzilianos;L. Brandén;D. Vidović;Caty Chung;S. Schürer;L. Tautz;D. Landry
中科院分区:
医学4区
文献类型:
--
作者:
Yuli Xie;Yidong Liu;G. Gong;A. Rinderspacher;S. Deng;Deborah H. Smith;Udo Toebben;Effie Tzilianos;L. Brandén;D. Vidović;Caty Chung;S. Schürer;L. Tautz;D. Landry

文献摘要

被引文献

相似文献

We report here a class of thiazolidine-2,4-diones and 2-thioxothiazolidin-4-ones as potent inhibitors of the lymphoid specific tyrosine phosphatase (Lyp) identified from high throughput screens. Chemical modification by incorporating the known phosphotyrosine (pTyr) mimics led to the discovery of a salicylate-based inhibitor with submicromolar potency.